Status:
COMPLETED
Helping Hypertension Patients to Interpret Blood Pressure Readings and Motivate Blood Pressure Control
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
University of Pittsburgh
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hypertension is a major risk factor for cardiovascular disease, and a leading cause of death worldwide. Only about 50% of hypertension patients have good blood pressure control, perhaps because they f...
Detailed Description
BACKGROUND Hypertension is a major modifiable risk factor for cardiovascular disease, and a leading cause of death worldwide. Lifetime risk of hypertension is 70-90%, but it is higher among adults who...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosed with hypertension
- Proficient in English
Exclusion
Key Trial Info
Start Date :
March 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 5 2022
Estimated Enrollment :
542 Patients enrolled
Trial Details
Trial ID
NCT04485637
Start Date
March 23 2022
End Date
April 5 2022
Last Update
May 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pitt+Me Patient Registry
Pittsburgh, Pennsylvania, United States, 15213